Trial Profile
Nitric Oxide during Cardio Pulmonary Bypass during surgery for congenital heart defects: A Randomised Controlled Trial.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Congenital heart defects
- Focus Therapeutic Use
- 21 May 2019 New trial record